Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Colostrum, the first form of milk produced by mammals after giving birth, is rich in immunoglobulins, growth factors, and bioactive molecules. Its use to support patients undergoing chemotherapy is supported by some scientific evidence, primarily relating to the management of chemotherapy-induced gastrointestinal side effects, such as oral mucositis and diarrhea. Several small clinical trials and pilot studies have indicated that bovine colostrum supplementation can reduce the severity and duration of oral mucositis in patients receiving chemotherapy or radiotherapy, likely due to its anti-inflammatory and epithelial-healing properties. For instance, a randomized controlled trial published in "Supportive Care in Cancer" (2016) demonstrated that patients receiving bovine colostrum had a lower incidence of severe oral mucositis compared to placebo. Other studies suggest potential benefits in reducing gastrointestinal symptoms like diarrhea, possibly by enhancing mucosal barrier function and modulating gut immunity.

However, despite these promising findings, the overall quality of evidence remains moderate, with limitations including small sample sizes, short study durations, and variability in colostrum preparations. Larger, well-designed randomized controlled trials are needed to confirm these benefits and clarify optimal dosing and safety. While colostrum is not a standard mainstream intervention for chemotherapy side effects, its use is supported by a growing body of scientific literature, particularly as an adjunct to conventional supportive care.

More about colostrum
More about Chemotherapy (reducing side effects)

Other ingredients used for Chemotherapy (reducing side effects)

Other health conditions supported by colostrum

Products containing colostrum

Nature's Sunshine Colostrum
Nature's Sunshine Colostrum (With Immune Factors)
Nature's Sunshine Immune System
Nature's Sunshine Immune Stimulator